Research & Studies

Research & Studies

Supplemental Oxygen Eliminates Morning Blood Pressure Rise in OSA Patients Following CPAP Withdrawal

Supplemental oxygen eliminates the rise in morning blood pressure experienced by obstructive sleep apnea (OSA) patients who stop using continuous positive airway pressure (CPAP), the standard treatment for OSA, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine. In “Effect […]

cannabis
Research & Studies Sleep Apnea

Clinical Trial for Treating OSA Using Cannabinoid-based Drug

Therapix Biosciences Ltd., a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, announced that on June 05, 2018, the first subject was enrolled for its Phase IIa, sponsor-initiated clinical trial using the Company’s cannabinoid-based technology THX-110 for Obstructive Sleep Apnea (OSA), at Assuta Medical Center, the largest […]

Research & Studies

New Data Shows Combined COPD Treatments Could Help Reduce Annual Cost of Care

Economic analysis of Philips-sponsored study shows cost savings of more than $3,900 per patient in the United States by combining non-invasive ventilation with home oxygen therapy This week at the American Thoracic Society (ATS) Conference 2018, Royal Philips, announced new data suggesting that combining home oxygen therapy (HOT) with home non-invasive ventilation (HMV) as […]

Research & Studies

Eisai and Purdue Pharma Announce Key Phase 1 Clinical Studies of Lemborexant to be Presented at SLEEP 2018

Eisai Co., Ltd. and Purdue Pharma L.P. yesterday announced that two key Phase 1 clinical studies (Study 108 and Study 106) of their investigational sleep/wake regulation agent lemborexant, including a comparison versus zolpidem tartrate extended release (zolpidem ER) and placebo on postural stability and other variables after middle-of-the-night awakening and […]